All Stories

  1. Discovery of novel host target of COVID-19

    Article • F1000Research, January 2020, Faculty of 1000, Ltd.

    Dr Veljko Veljkovic

  2. Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection

    Article • F1000Research, March 2016, Faculty of 1000, Ltd.

    Dr Veljko Veljkovic

  3. Possible repurposing of seasonal influenza vaccine for prevention of Zika virus infection

    Article • F1000Research, February 2016, Faculty of 1000, Ltd.

    Dr Veljko Veljkovic, Veljko Veljkovic

  4. Improving attrition rates in Ebola virus drug discovery

    Article • Expert Opinion on Drug Discovery, June 2015, Informa Healthcare

    Dr Veljko Veljkovic

  5. In silico analysis suggests repurposing of ibuprofen for prevention and treatment of EBOLA virus disease

    Article • F1000Research, May 2015, Faculty of 1000, Ltd.

    Dr Veljko Veljkovic

  6. In silico analysis suggests interaction between Ebola virus and the extracellular matrix

    Article • Frontiers in Microbiology, February 2015, Frontiers

    Dr Veljko Veljkovic

  7. Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection

    Article • F1000Research, February 2015, Faculty of 1000, Ltd.

    Dr Veljko Veljkovic

  8. Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection

    Article • F1000Research, February 2015, Faculty of 1000, Ltd.

    Dr Veljko Veljkovic, Bruno Figadere

  9. Influenza vaccine as prevention for cardiovascular diseases: Possible molecular mechanism

    Article • Vaccine, November 2014, Elsevier

    Dr Veljko Veljkovic

  10. Simple and General Criterion for “in silico” Screening of Candidate HIV Drugs

    Article • Current Pharmaceutical Biotechnology, November 2013, Bentham Science Publishers

    Dr Veljko Veljkovic

  11. The role of long-range intermolecular interactions in discovery of new drugs

    Article • Expert Opinion on Drug Discovery, November 2011, Informa Healthcare

    Dr Veljko Veljkovic

  12. Discovery of New Therapeutic Targets by the Informational Spectrum Method

    Article • Current Protein and Peptide Science, October 2008, Bentham Science Publishers

    Dr Veljko Veljkovic

  13. AIDS vaccine: Efficacy, safety and ethics

    Article • Vaccine, June 2008, Elsevier

    Dr Veljko Veljkovic

  14. Simple criterion for selection of flavonoid compounds with anti-HIV activity

    Article • Bioorganic & Medicinal Chemistry Letters, March 2007, Elsevier

    Dr Veljko Veljkovic

  15. MOLECULAR MAKEUP OF HIV-1 ENVELOPE PROTEIN

    Article • International Reviews of Immunology, January 2004, Taylor & Francis

    Dr Veljko Veljkovic

  16. SAFETY AND ETHICAL CONSIDERATION OF AIDS VACCINE

    Article • International Reviews of Immunology, January 2004, Taylor & Francis

    Dr Veljko Veljkovic

  17. RECOMBINATION PROPERTY OF THE HIV-1 gp120 GENE

    Article • International Reviews of Immunology, January 2004, Taylor & Francis

    Dr Veljko Veljkovic

  18. HIV-1 gp120 AND IMMUNE NETWORK

    Article • International Reviews of Immunology, January 2004, Taylor & Francis

    Dr Veljko Veljkovic

  19. AIDSVAX results: an important open question

    Article • Vaccine, September 2003, Elsevier

    Dr Veljko Veljkovic

  20. Does VaxGen hide the breakthrough infections?

    Article • The Lancet, May 2003, Elsevier

    Dr Veljko Veljkovic

  21. The Role of Passive Immunization in HIV-Positive Patients

    Article • CHEST Journal, August 2001, Elsevier

    Dr Veljko Veljkovic